CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $21.58 million as of 2014-03-29, per its 10-Q filed 2014-04-30.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2014-04-30
- 2014-03-29: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $21.58M.
- 2013-12-28: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $9.04M; Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value as first filed $20.58M.
- 2013-09-28: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $14.58M.
- 2013-06-29: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $11.68M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value as first filed |
|---|---|---|
| 2014-03-29 | $21.58M 10-Q · filed 2014-04-30 | |
| 2013-12-28 | $9.04M 10-Q · filed 2014-04-30 | $20.58M 10-K · filed 2014-02-25 |
| 2013-09-28 | $14.58M 10-Q · filed 2013-10-30 | |
| 2013-06-29 | $11.68M 10-Q · filed 2013-07-31 | |
| 2013-03-30 | $9.04M 10-Q · filed 2013-05-08 | |
| 2012-12-29 | $0.00 10-Q · filed 2014-04-30 | |
| 2011-12-31 | $0.00 10-Q · filed 2013-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |